Xometry stock hits 52-week high at 55.57 USD

Published 23/09/2025, 14:44
Xometry stock hits 52-week high at 55.57 USD

Xometry Inc stock reached a significant milestone, hitting a 52-week high of 55.57 USD. According to InvestingPro data, the company’s market capitalization now stands at $2.79 billion, with analysts maintaining a bullish stance as four have recently revised their earnings expectations upward. This achievement underscores a remarkable year for the company, as the stock has surged by 193.65% over the past 12 months. The impressive growth reflects strong investor confidence, supported by expected profitability this year and revenue growth of 20.19%. While current metrics suggest the stock is trading above its Fair Value, the 52-week high marks a pivotal point for Xometry, highlighting its upward trajectory and potential for future gains. For deeper insights and 12 additional ProTips about Xometry’s performance, visit InvestingPro.

In other recent news, Xometry Inc. reported strong financial results for the second quarter of 2025, significantly exceeding analyst expectations. The company achieved earnings per share of $0.09, more than doubling the forecast of $0.0439, resulting in a 105.01% surprise. Revenue also surpassed forecasts, reaching $163 million compared to an expected $156.49 million, marking a 3.87% surprise. Following these results, JPMorgan raised its price target for Xometry to $55, citing strong marketplace growth and a 26% year-over-year increase in marketplace revenue. Citizens JMP also adjusted its price target to $50, highlighting that Xometry’s revenue and EBITDA exceeded guidance by $5.5 million and $1.9 million, respectively. UBS increased its price target to $40 from $35, maintaining a Neutral rating due to the company’s robust second-quarter performance. Additionally, Citizens JMP maintained its Market Outperform rating, emphasizing the role of artificial intelligence as a key growth driver for the company. These developments underscore the positive outlook from analysts regarding Xometry’s financial health and growth potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.